Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2021 Aug 2;11:15619. doi: 10.1038/s41598-021-95114-3

The incremental value of computed tomography of COVID-19 pneumonia in predicting ICU admission

Maurizio Bartolucci 1, Matteo Benelli 2, Margherita Betti 3, Sara Bicchi 3, Luca Fedeli 3, Federico Giannelli 4, Donatella Aquilini 5, Alessio Baldini 6, Guglielmo Consales 7, Massimo Edoardo Di Natale 8, Pamela Lotti 8, Letizia Vannucchi 9, Michele Trezzi 10, Lorenzo Nicola Mazzoni 3, Sandro Santini 11, Roberto Carpi 12, Daniela Matarrese 13, Luca Bernardi 3, Mario Mascalchi 14,15,; the COVID Working Group
PMCID: PMC8329253  PMID: 34341411

Abstract

Triage is crucial for patient’s management and estimation of the required intensive care unit (ICU) beds is fundamental for health systems during the COVID-19 pandemic. We assessed whether chest computed tomography (CT) of COVID-19 pneumonia has an incremental role in predicting patient’s admission to ICU. We performed volumetric and texture analysis of the areas of the affected lung in CT of 115 outpatients with COVID-19 infection presenting to the emergency room with dyspnea and unresponsive hypoxyemia. Admission blood laboratory including lymphocyte count, serum lactate dehydrogenase, D-dimer and C-reactive protein and the ratio between the arterial partial pressure of oxygen and inspired oxygen were collected. By calculating the areas under the receiver-operating characteristic curves (AUC), we compared the performance of blood laboratory-arterial gas analyses features alone and combined with the CT features in two hybrid models (Hybrid radiological and Hybrid radiomics)for predicting ICU admission. Following a machine learning approach, 63 patients were allocated to the training and 52 to the validation set. Twenty-nine (25%) of patients were admitted to ICU. The Hybrid radiological model comprising the lung %consolidation performed significantly (p = 0.04) better in predicting ICU admission in the validation (AUC = 0.82; 95% confidence interval 0.73–0.97) set than the blood laboratory-arterial gas analyses features alone (AUC = 0.71; 95% confidence interval 0.56–0.86). A risk calculator for ICU admission was derived and is available at: https://github.com/cgplab/covidapp. The volume of the consolidated lung in CT of patients with COVID-19 pneumonia has a mild but significant incremental value in predicting ICU admission.

Subject terms: Biomarkers, Diseases, Health care

Introduction

In January 2020 the World Health Organization declared Coronavirus disease (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) a public health emergency of international concern. Until December 2020 it has caused more than 80 million of cases and more than 1.7 million of deaths worldwide1.

About 15% of patients with COVID-19 pneumonia show a severe disease course requiring hospitalization and 5% eventual admission to an intensive care unit (ICU)2,3.

Prediction of ICU admission is crucial for patient’s management and forecasting the required number of ICU beds is fundamental for the resources allocation and organization of the health systems during the COVID-19 pandemic4. Hence prediction of ICU admission has been frequently investigated in studies addressing diagnostic and prognostic models for COVID-195. Among the variables potentially useful for such a purpose, clinical features yielded mixed results612, while blood laboratory and arterial gas analysis features generally improved the overall prediction capacity8,10,11,1316.

Due to the non-specificity of findings, chest radiographs and computed tomography (CT) have no major diagnostic role in patients with SARS-CoV-217,18. Moreover the American College of Radiology and Society of Thoracic Radiology in the United States cautioned against their widespread use for assessment and monitoring disease course18. However, the Fleischner society stated (1) that imaging is indicated in a patient with Covid-19 and worsening respiratory status and (2) that in a resource-constrained environment, imaging is indicated for triage of patients suspected of having Covid-19 who present with moderate-to-severe clinical features and a high pretest probability of disease19. Moreover, several studies in Asia, Europe and United States have indicated that chest radiographs and CT may have a role in the prediction of clinical evolution including need of ICU admission2027.

We hypothesized that CT-based quantitative analysis of the volume of the affected lung and its characterization in terms of texture analysis28 might have an incremental role with respect to blood laboratory and arterial gas analysis results in predicting the patient’s admission to ICU. To explore this hypothesis following a machine learning approach we compared the predictive value of blood laboratory and arterial gas analysis features alone with those of two hybrid models combining the same features with those derived from CT.

Methods

The study received ethical approval (Protocol Number: 17260_oss) by the local Ethical Committee (Comitato Etico Regionale per la Sperimentazione Clinica della Regione Toscana Sezione Area Vasta Centro) and was performed between March 7th and November 8th 2020 at the Prato and Pistoia community hospitals in the Tuscany region of Italy, where overall 3–12% of hospital beds were allocated to ICUs in the study time period. The same Ethical Committee waived the need of consent for participants to the study which was performed in accordance with the Declaration of Helsinki guidelines.

The study involved 208 outpatients with COVID-19 infection confirmed by positive nucleic acid test of real time-PCR in nasal-pharyngeal swabs who presented to the Emergency Room (ER) and underwent immediate unenhanced chest CT because of dyspnea and non-responsive hypoxiemia.

Laboratory data on admission included routine blood tests, serum lactate dehydrogenase (LDH), D-dimer and C-reactive protein (CRP) and lymphocytes count. Moreover in each patient the Horowitz (P/F) Index was calculated as the ratio between the arterial partial pressure of oxygen [PaO2] measured (in mmHg) by blood gas analysis and fraction of inspired oxygen [FiO2]. Patient’s age and gender and co-morbidities including history of arterial hypertension, diabetes, heart diseases and malignancies were annotated. Subsequent admission to the ICU and patient’s death were recorded as of November 13th, 2020.

Patients with CT images of low quality or incomplete blood laboratory or arterial blood gas analyses were excluded. Accordingly, data were analyzed in 115 of the initial 208 patients. Following a machine-learning approach and to avoid a “peeking” effect29,30, 63 patients observed between March 7th and April 21st, 2020 during the first wave of COVID-19 pandemic in Italy constituted the training set and 52 patients observed between August 18th and November 8th 2020 during the second wave constituted the validation set. Figure 1 shows the study flow-chart.

Figure 1.

Figure 1

Study flow-chart. CT computed tomography, ER emergency room, ICU intensive care unit, SARS-Cov-2 severe acute respiratory syndrome coronavirus 2.

The chest CT examinations were performed in Prato (n = 88) on a Siemens SOMATOM Sensation 64-rows of detectors scanner or in Pistoia (n = 27) on an Optima CT660 GE Medical System 16-rows of detectors scanner. The patients were examined in supine position during inspiratory breath-hold or spontaneous breathing. CT acquisition parameters were set as follows: tube voltage 120 kV, tube current modulation from CareDose4D technology with quality reference mAs 150, pitch 1.4, slice thickness 0.6 mm in the Siemens scanner and tube voltage 120 kV, tube current modulation Smart mA technology, pitch 1.0, slice thickness 0.6 mm, in the GE scanner. Reconstruction filter used was B30 medium smooth for both the scanners and reconstruction was performed with slice thickness ranging from 2.5 and 3 mm in order to allow segmentation software to manage the amount of data in an appropriate time frame.

The CT images were transferred to a workstation implemented with the MIM Maestro software (MIM Software Inc.). Three Regions of Interest (RoIs) were automatically created from both lungs: Well-Areated Lung (WAL), which comprises the entire healthy tissue, Ground Glass Opacities (GGO), which includes areas showing ground glass density, and Consolidation (Consolid), which corresponds to areas of consolidated tissue. For segmentation of WAL and GGO, we used the Region Growing tool and threshold intervals were set from − 950 Hounsfield Units (HU) to − 700 HU for WAL 22 and from − 700 to − 250 HU for GGO31. For ConsolidRoI, a single expert radiologist with 20 years of experience in lung CT (M.B.) blind to the patient's clinical, blood laboratory and arterial gas analyses results performed a manual editing of the segmentation results. An example is shown in Supplementary Fig. 1. The fraction of each RoI with respect to total lung volume was calculated. For image texture analysis, 107 radiomic features listed in Supplementary material Table 1 were extracted using the 3DSlicer software32 and the module radiomic33. Image texture features were processed and analyzed by RadAR (Radiomics Analysis with R)34. Features with duplicated ids and shape features (n = 21) were excluded from downstream analysis.

Statistical analysis and model construction

We used two-sided Wilcoxon–Mann–Whitney test to assess statistical significance of the differences between the ICU and non-ICU patients groups for parametric variables and Fisher’s Exact test for age and gender. Since co-morbidities can determine distortions in the admission to the ICU, especially when there is a relative shortage of dedicated beds, they were not included in the models.

Models to predict ICU admission were built using binomial regression with GLMNET35 on continuous variables, considering ICU admission as response variable (0 = no, 1 = yes). We selected GLMNET because, differently from other methods as multivariate random forest, it enables simultaneous selection of relevant features and parameter estimation. We built 5 models using age, blood laboratory features, the P/F ratio, the radiological and the radiomics features. The description of each feature is reported in Supplementary Table 1. To select relevant features for each model (feature selection), predictors showing nonzero coefficient at lambda.min—corresponding to the value of the regularization parameter lambda that gives minimum mean cross-validated error—were considered. To facilitate the applicability of our approach, GLMNET models were then rebuilt considering only model-specific selected features.

The performance of each model was assessed by calculating the area under the receiver operating characteristic curves (AUC) in the training and validation sets, using model probability as threshold parameter. All the analyses were performed using the R statistical programming language (https://cran.r-project.org/).

The confidence intervals of AUCs and the statistical significance of pairwise difference between AUCs were estimated by De Long’s tests implemented in the pROC R package36.

Web application

An interactive web application implementing the three best performing models (see below) was built using Shiny (https://CRAN.R-project.org/package=shiny).

Statistics and biometry

Matteo Benelli kindly provided statistical advice for this manuscript. He has significant statistical expertise.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

Prospective.

Observational.

Two-center study.

Results

Twenty-nine (19 of the training and10 of validation set) of the 115 included patients were admitted to ICU. The average interval between ER presentation and ICU admission was 1.9 days (range 1–22) in the training and 2.6 (range 1–5) in the validation set.

Table 1 details the distribution of age, gender, number of co-morbidities, blood laboratory and arterial gas analyses results and of those of the CT in the patients of the training and validation sets. In both sets the P/F index and %WAL were significantly lower and the %Consolid significantly higher in patients admitted to ICU. Comparing the data in the training and validation sets, only LDH was significantly higher (p = 0.004) and the age lower (p = 0.01) in the patients of the validation set who were not admitted to ICU.

Table 1.

Clinical, blood laboratory, arterial gas analyses and CT results in patients with COVID-19 pneumonia.

Training (March 7–April 21, 2020) set Validation (August 18–November 8, 2020) set
No ICU admission (n = 44) ICU admission (n = 19) p value No ICU admission (n = 42) ICU admission (n = 10) p value
Age, years 68 ± 12 66 ± 10 0.27 61 ± 3 72 ± 7 0.006
Gender 0.55 1
Male n = 32 (73%) n = 12 (63%) n = 23 (58%) n = 7 (58%)
Female n = 12 (27%) n = 7 (37%) n = 17 (42%) n = 5 (42%)
Comorbodities 0.58 0.59
0 n = 4 (11%) n = 4 (27%) n = 11 (30%) n = 2 (20%)
1 n = 19 (51%) n = 7 (47%) n = 15 (41%) n = 6 (60%)
2 n = 10 (27%) n = 3 (20%) n = 6 (16%) n = 2 (20%)
> 2 n = 4 (11%) n = 1 (7%) n = 5 (14%) n = 0 (0%)
LDH (UI/L) 288 ± 127 371 ± 100 0.002 363 ± 135 400 ± 83 0.18
D-dimer (µg/mL FEU) 1.6 ± 2.6 2.2 ± 2.1 0.25 1.1 ± 1.0 2.0 ± 2.2 0.10
CRP (mg/dL) 9  ± 8 11 ± 9 0.35 6 ± 5 16 ± 10 0.0002
Lymphocytes(103/uL) 1.1 ± 0.6 1.2 ± 1.2 0.63 1.2 ± 1.9 0.8 ± 0.4 0.21
P/F (mmHg) 236 ± 97 153 ± 66 0.001 243 ± 92 126 ± 47 0.00009
% Consolidation 5 ± 4 13 ± 10 0.0007 4 ± 4 8 ± 6 0.017
% Ground glass 19 ± 16 29 ± 16 0.008 20 ± 15 26 ± 10 0.06
% Normal lung 76 ± 18 58 ± 20 0.0009 76 ± 17 66 ± 11 0.026

Continuous values are expressed as mean ± standard deviation.

P/F = ratio between the arterial partial pressure of oxygen [PaO2] measured (in mmHg) by blood gas analysis and fraction of inspired oxygen [FiO2].

CRP serum C-reactive protein, ICU intensive care unit, LDH serum lactate dehydrogenase.

Table 2 summarizes the considered features and those selected by the GLMNET. Age, LDH and the P/F ratio were selected as the best features both in the blood laboratory and arterial gas analyses model and in the Hybrid radiological model which also comprised %consolid. The Hybrid radiomics model comprised the P/F ratio, LDH, %consolid and 3 of the 86 considered texture features (see Table 1 and Supplementary Table 1).

Table 2.

Features a priori considered and features selected by GLMNET for their relevance in predicting ICU admission in five models.

Model Features Selected features (ICU admission)
Blood laboratory and arterial gas analyses Age, LDH, D-dimer, PCR, Lymphocytes, P/F Age, LDH, P/F
Radiological %consolid, %ground glass, %normal lung %consolid, %normal lung
Radiomics 86 radiomic features (see Supplementary Table 1) Dependence Non Uniformity, Small Dependence High Gray Level Emphasis, Large Dependence Low Gray Level Emphasis, Correlation, Interquartile Range, Total Energy, Run Variance, Large Area Low Gray Level Emphasis, Small Area Low Gray Level Emphasis
Hybrid radiological Age, LDH, D-dimer, PCR, Lymphocytes, P/F, %consolid, %ground glass, %normal lung Age, P/F, LDH, %consolid
Hybrid radiomics Age, LDH, D-dimer, PCR, Lymphocytes, P/F, %consolid, %ground glass, %normal lung, 86 radiomic features P/F, LDH, %consolid, Large Dependence Low Gray Level Emphasis, Run Length Non Uniformity, Low Gray Level Zone Emphasis

P/F = ratio between the arterial partial pressure of oxygen [PaO2] measured (in mmHg) by blood gas analysis and fraction of inspired oxygen [FiO2]; %consolid = percentage of consolidated lung; %ground glass = percentage of lung exhibiting ground glass opacities density; %normal lung = percentage of lung with normal density.

CRP serum C-reactive protein, ICU intensive care unit, LDH serum lactate dehydrogenase.

Figure 2 shows the AUC of the model based on blood laboratory and arterial gas analyses features alone and of the two Hybrid models. The Hybrid radiological model performed better in predicting admission to the ICU in both the training (AUC = 0.87; 95% Confidence Interval 0.77–0.97) and validation (AUC = 0.82; 95% Confidence Interval 0.73–0.97) set as compared to the blood laboratory-arterial blood gas analyses features alone (training AUC = 0.84; 95% Confidence Interval 0.68–0.95) (validation AUC = 0.71; 95% Confidence Interval 0.56–0.86). The difference was significant (p = 0.04) in the validation set. Also the Hybrid radiomics model performed better than the blood laboratory-arterial blood gas analyses features alone in the two sets, but the differences were not significant.

Figure 2.

Figure 2

Performance of 3 models in predicting ICU admission. Receiving Operating Characteristic (ROC) curve analysis of the blood laboratory-arterial gas analyses features (dotted line), Hybrid radiological features (solid line) and Hybrid radiomics features (dashed line) in the training (A) and validation (B) sets. The values reported in parentheses refer to Area Under the ROC curves.

The models evaluating radiological and radiomics features alone selected two (%consolid and %WAL) and seven features(see Supplementary Table 1), respectively, but performed worse than the model evaluating blood laboratory and arterial gas analyses results in predicting ICU admission (see Supplementary Fig. 2).

The distribution of the probability of ICU admission in the validation set (Supplementary Fig. 3) indicates that no patient required ICU admission below the threshold of 0.25, 0.15 and 0.05 for the blood laboratory-arterial gas analyses model, Hybrid radiological and Hybrid radiomic models, respectively. In particular, in the Hybrid radiological model all patients with estimated probability below 0.20, corresponding to 16 (30%) of 52 patients, were all correctly classified and identified as a low-risk population without need of ICU admission.

The application to estimate the patient’s probability of ICU admission with the three best performing models is freely available at https://github.com/cgplab/covidappunder MIT license and allows users using the proposed models after insertion of the required model-specific features.

Mortality rates were 14% (9/63) in the training and 21% (11/52) in the validation set.

Discussion

Admission to ICU, where the most invasive and sophisticated treatments are carried out, is associated with a number of variables, including the evaluation of the patient’s clinical severity and evolution and the availability of ICU beds, but generally implies a severe structural and functional lung compromise, worse prognosis and increasing costs.

In this study we holistically combined blood laboratory, arterial gas analyses and CT results at ER presentation to predict ICU admission in patients with COVID-19 pneumonia. We demonstrated that the Hybrid radiological model combining CT estimation of volume of the consolidated lung with blood laboratory and arterial gas analyses features has a mild but significant incremental predictive value with respect to the model considering blood laboratory and arterial gas analyses features alone. This result is in line with and reinforces data from prior studies which evaluated the contribute of CT in predicting ICU admission in hybrid models22,2426.

For comparison with CT we considered several established blood biomarkers of severity of COVID-19 pneumonia including serum LDH, D-dimer, CRP and lymphocyte counts that can predict ICU admission10,12,13,15,16,24. As well, we considered the P/F ratio which is a marker of non-responsive hypoxiemia in these patients10,14,16.

Notably, in both our hybrid models the volume of consolidated lung, that is correlated with lung weight and reflects infiltrates on chest radiographs, was the best radiological feature selected by the model instead than the volume of the well areated lung, that is the CT biomarker commonly used for Acute Respiratory Distress Syndrome (ARDS)22,37,38. This is in line with the observation that the pathological and radiological features of COVID-19 pneumonia are not typical of ARDS. In fact COVID-19 pneumonia along with diffuse alveolar damage and organizing pneumonia is characterized by a prominent vascular compromise justifying the observed disproportionate and non-responsive hypoxyemia39,40 and the term “CARDS” (COVID-19 ARDS)41 to label it. Moreover, according to Gattinoni et al.42, consolidation and its extent characterizes two phenotypes of CARDS named type L (Low elastance, Low ventilation-to perfusion ratio, Low lung weight and Low recruitability) and type H (High elastance, High ventilation-to perfusion ratio, High lung weight and High recruitability) “which are best identified by CT”, involve different pathophysiological mechanisms and require different treatment options that, in case of type H, include intubation, positive end-expiratory pressure and extracorporeal membrane oxygenation that pertain to the ICU environment.

In our study, the Hybrid radiomics model including image texture features of the affected lung slightly (and not significantly) improved prediction of ICU admission as compared with blood laboratory and arterial gas analyses features. Two prior studies reported a marginal incremental value of Radiomics for prediction of ICU admission as compared to volume estimation of the affected lung25,26. Notably, since the Hybrid radiomics was the best performing model in our training set, but showed non-significant advantage compared to blood laboratory and arterial gas features in the validation set, we speculate that Hybrid radiomics models might be more affected by overfitting as compared to the Hybrid radiological model. Overall, also considering that the pathological correlates of the CT texture features analysis are uncertain28, we recommend estimation of the volume of lung consolidation and the Hybrid radiological model for triage of patients with COVID-19 pneumonia.

We recognize the following limitations of our study.

We performed a two centres study with relatively small sample sizes and assessment of the proposed models with data from other centres and greater sample sizes are required to verify their validity. In our models we considered a large array of continuous variables in different domains, including D-dimer and P/F ratio which reflect the more characteristic physiopathological features of COVID-19 pneumonia14,15,43 and are associated with worst prognosis44, but discarded some potentially relevant categorical variables as gender, obesity and co-morbidities45,46 which however are more closely linked with mortality than ICU admission. Moreover, the recently described ABO blood-group system and genetic susceptibility loci47 and some continuous variables as serum Interleukin-624,48, ferritin and procalcitonin16 were not available. Finally, we did not evaluate death as an outcome due to the small samples. However this would imply to consider treatments and other variables and was beyond the scope of the present investigation.

In conclusion, the combination of the volume of lung consolidation on CT at ER presentation has a mild but significant incremental value as compared to blood laboratory and arterial gas analyses results in predicting ICU admission. Inclusion of CT in the triage of patients with symptomatic COVID-19 pneumonia may have a practical value for individual patient’s management (possibly using the free application we developed) and help planning and organizing the Health Systems response to COVID-19 pandemic.

Supplementary Information

Abbreviations

ARDS

Acute respiratory distress syndrome

AUC

Area under the receiver operating characteristic curve

CARDS

COVID-19 ARDS

CRP

Serum C-reactive protein

ER

Emergency room

GGO

Ground glass opacities

ICU

Intensive care unit

LDH

Serum lactate dehydrogenase

P/F

Ratio between the arterial partial pressure of oxygen [PaO2] measured (in mmHg) by blood gas analysis and fraction of inspired oxygen [FiO2]

SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2

WAL

Well-areated lung

Author contributions

All the authors read and discussed the content of the article. M.Ba. conceived and performed the study. M.Ben. performed all statistical analyses, developed and tested the predictive models and realized the web free APP. M.Bet., S.B., L.F. and L.N.M. collected and preliminarily elaborated the data. F.G. performed literature review. A.B., D.A., M.T., G.C., M.E.D.N., P.L. had in charge COVID-19 patients in the Prato and Pistoia Hospitals, L.V., S.S. and R.C. developed and shared the CT examinations protocol, acquisitions and elaboration strategies. L.B .supervised the elaboration and analyses pipeline. D.M. was the Guarantor of the study. M.M. contributed to the study design, wrote the manuscript draft and critically discussed it. All the authors critically revised the final draft and approved.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

A list of authors and their affiliations appears at the end of the paper.

Contributor Information

Mario Mascalchi, Email: m.mascalchi@dfc.unifi.it.

the COVID Working Group:

Edoardo Cavigli, Alessandra Bindi, Diletta Cozzi, Vittorio Miele, Simone Busoni, Adriana Taddeucci, Germana Allescia, Chiara Zini, Giovanni Luca Dedola, Silvia Mazzocchi, Chiara Pozzessere, and Adriano Viviani

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-021-95114-3.

References

  • 1.Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020;20:533–534. doi: 10.1016/S1473-3099(20)30120-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Centers for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). 2020. https://stacks.cdc.gov/view/cdc/88624. Accessed 21 August 2020.
  • 3.Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi: 10.1001/jama.2020.2648. [DOI] [PubMed] [Google Scholar]
  • 4.Rosenbaum L. Facing Covid-19 in Italy—Ethics, logistics, and therapeutics on the epidemic's front line. N. Engl. J. Med. 2020;382(20):1873–1875. doi: 10.1056/NEJMp2005492. [DOI] [PubMed] [Google Scholar]
  • 5.Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19 infection: Systematic review and critical appraisal. BMJ. 2020;7:369. doi: 10.1136/bmj.m1328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gidari A, De Socio GV, Sabbatini S, Francisci D. Predictive value of national early warning score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection. Infect. Dis. (Lond.) 2020;52(10):698–704. doi: 10.1080/23744235.2020.1784457. [DOI] [PubMed] [Google Scholar]
  • 7.Rodriguez-Nava G, Yanez-Bello MA, Trelles-Garcia DP, Chung CW, Friedman HJ, Hines DW. Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting. Int. J. Infect. Dis. 2020;S1201–9712(20):32314–32316. doi: 10.1016/j.ijid.2020.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hashmi MD, Alnababteh M, Vedantam K, Alunikummannil J, Oweis ES, Shorr AF. Assessing the need for transfer to the intensive care unit for Coronavirus-19 disease: Epidemiology and risk factors. Respir. Med. 2020;174:106203. doi: 10.1016/j.rmed.2020.106203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Al Hassan H, Cocks E, Jesani L, Lewis S, Szakmany T. Clinical risk prediction scores in coronavirus disease 2019: Beware of low validity and clinical utility. Crit. Care Explor. 2020;2(10):e0253. doi: 10.1097/CCE.0000000000000253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gude F, Riveiro V, Rodríguez-Núñez N, et al. Development and validation of a clinical score to estimate progression to severe or critical state in COVID-19 pneumonia hospitalized patients. Sci. Rep. 2020;10(1):19794. doi: 10.1038/s41598-020-75651-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hao B, Sotudian S, Wang T, et al. Early prediction of level-of-care requirements in patients with COVID-19. Elife. 2020;9:e60519. doi: 10.7554/eLife.60519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Allenbach Y, Saadoun D, Maalouf G, et al. Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients. PLoS ONE. 2020;15(10):e0240711. doi: 10.1371/journal.pone.0240711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kiss S, Gede N, Hegyi P, et al. Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: A systematic review and meta-analysis. Med. Microbiol. Immunol. 2020;21:1–15. doi: 10.1007/s00430-020-00696-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kostakis I, Smith GB, Prytherch D, et al. The performance of the national early warning score and national early warning score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2. Resuscitation. 2020;S0300–9572(20):30548–30557. doi: 10.1016/j.resuscitation.2020.10.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bansal A, Singh AD, Jain V, et al. The association of D-dimers with mortality, intensive care unit admission or acute respiratory distress syndrome in patients hospitalized with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Heart Lung. 2021;50(1):9–12. doi: 10.1016/j.hrtlng.2020.08.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Li X, Ge P, Zhu J, et al. Deep learning prediction of likelihood of ICU admission and mortality in COVID-19 patients using clinical variables. PeerJ. 2020;8:e10337. doi: 10.7717/peerj.10337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jamil S, Mark N, Carlos G, Cruz CSD, Gross JE, Pasnick S. Diagnosis and Management of COVID-19 Disease. Am. J. Respir. Crit. Care Med. 2020;201(10):P19–P20. doi: 10.1164/rccm.2020C1. [DOI] [PubMed] [Google Scholar]
  • 18.ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection. 2020. Available at: https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection.
  • 19.Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, Schluger NW, Volpi A, Yim JJ, Martin IBK, Anderson DJ, Kong C, Altes T, Bush A, Desai SR, Goldin J, Goo JM, Humbert M, Inoue Y, Kauczor HU, Luo F, Mazzone PJ, Prokop M, Remy-Jardin M, Richeldi L, Schaefer-Prokop CM, Tomiyama N, Wells AU, Leung AN. The role of chest imaging in patient management during the COVID-19 pandemic: A multinational consensus statement from the Fleischner Society. Chest. 2020;158(1):106–116. doi: 10.1016/j.chest.2020.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schalekamp S, Huisman M, van Dijk RA, et al. Model-based prediction of critical illness in hospitalized patients with COVID-19. Radiology. 2021;298(1):E46–E54. doi: 10.1148/radiol.2020202723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Balbi M, Caroli A, Corsi A, et al. Chest X-ray for predicting mortality and the need for ventilatory support in COVID-19 patients presenting to the emergency department. Eur. Radiol. 2020;8:1–14. doi: 10.1007/s00330-020-07270-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Colombi D, Bodini FC, Petrini M, et al. Well-aerated lung on admitting chest CT to predict adverse outcome in COVID-19 pneumonia. Radiology. 2020;296(2):E86–E96. doi: 10.1148/radiol.2020201433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lee KS. Pneumonia associated with 2019 novel coronavirus: Can Computed tomographic findings help predict the prognosis of the disease? Korean J. Radiol. 2020;21(3):257–258. doi: 10.3348/kjr.2020.0096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Burian E, Jungmann F, Kaissis GA, et al. Intensive care risk estimation in COVID-19 pneumonia based on clinical and imaging parameters: Experiences from the munich cohort. J. Clin. Med. 2020;9(5):1514. doi: 10.3390/jcm9051514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cai W, Liu T, Xue X, et al. CT quantification and machine-learning models for assessment of disease severity and prognosis of COVID-19 patients. Acad. Radiol. 2020;27(12):1665–1678. doi: 10.1016/j.acra.2020.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chao H, Fang X, Zhang J, et al. Integrative analysis for COVID-19 patient outcome prediction. Med. Image Anal. 2021;67:101844. doi: 10.1016/j.media.2020.101844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Lieveld AWE, Azijli K, Teunissen BP, van Haaften RM, Kootte RS, van den Berk IAH, van der Horst SFB, de Gans C, van de Ven PM, Nanayakkara PWB. Chest CT in COVID-19 at the ED: Validation of the COVID-19 reporting and data system (CO-RADS) and CT severity score: A prospective, multi-center, observational study. Chest. 2020;S0012–3692(20):35311–35313. doi: 10.1016/j.chest.2020.11.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ. CT texture analysis: Definitions, applications, biologic correlates, and challenges. Radiographics. 2017;37(5):1483–1503. doi: 10.1148/rg.2017170056. [DOI] [PubMed] [Google Scholar]
  • 29.Smialowski P, Frishman D, Kramer S. Pitfalls of supervised feature selection. Bioinformatics. 2010;26(3):440–443. doi: 10.1093/bioinformatics/btp621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Diciotti S, Ciulli S, Mascalchi M, Giannelli M, Toschi N. The "peeking" effect in supervised feature selection on diffusion tensor imaging data. AJNR Am. J. Neuroradiol. 2013;34(9):E107. doi: 10.3174/ajnr.A3685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lederer DJ, Enright PL, Kawut SM, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: The multi-ethnic study of atherosclerosis (MESA)-lung study. Am. J. Respir. Crit. Care Med. 2009;180(5):407–414. doi: 10.1164/rccm.200812-1966OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the quantitative imaging network. Magn. Reson. Imaging. 2012;30(9):1323–1341. doi: 10.1016/j.mri.2012.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104–e107. doi: 10.1158/0008-5472.CAN-17-0339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Benelli M, Barucci A, Zoppetti N, et al. Comprehensive analysis of radiomic datasets by RadAR. Cancer Res. 2020;80(15):3170–3174. doi: 10.1158/0008-5472.CAN-20-0332. [DOI] [PubMed] [Google Scholar]
  • 35.Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 2010;33(1):1–22. doi: 10.18637/jss.v033.i01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Robin X, Turck N, Hainard A, et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. doi: 10.1186/1471-2105-12-77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N. Engl. J. Med. 2006;354(17):1775–1786. doi: 10.1056/NEJMoa052052. [DOI] [PubMed] [Google Scholar]
  • 38.Nishiyama A, Kawata N, Yokota H, et al. A predictive factor for patients with acute respiratory distress syndrome: CT lung volumetry of the well-aerated region as an automated method. Eur. J. Radiol. 2020;122:108748. doi: 10.1016/j.ejrad.2019.108748. [DOI] [PubMed] [Google Scholar]
  • 39.Patel BV, Arachchillage DJ, Ridge CA, et al. Pulmonary angiopathy in severe COVID-19: Physiologic, imaging, and hematologic observations. Am. J. Respir. Crit. Care Med. 2020;202(5):690–699. doi: 10.1164/rccm.202004-1412OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a "typical" acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2020;201(10):1299–1300. doi: 10.1164/rccm.202003-0817LE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323(22):2329–2330. doi: 10.1001/jama.2020.6825. [DOI] [PubMed] [Google Scholar]
  • 42.Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: Different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099–1102. doi: 10.1007/s00134-020-06033-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Tobin MJ, Laghi F, Jubran AN. Why COVID-19 silent hypoxemia is baffling to physicians. Am. J. Respir. Crit. Care Med. 2020;202(3):356–360. doi: 10.1164/rccm.202006-2157CP. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: A multicentre prospective observational study. Lancet Respir. Med. 2020;8(12):1201–1208. doi: 10.1016/S2213-2600(20)30370-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Yang J, Tian C, Chen Y, Zhu C, Chi H, Li J. Obesity aggravates COVID-19: An updated systematic review and meta-analysis. J. Med. Virol. 2020 doi: 10.1002/jmv.26677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Iaccarino G, Grassi G, Borghi C, et al. Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension. PLoS ONE. 2020;15(10):e0237297. doi: 10.1371/journal.pone.0237297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Severe Covid-19 GWAS Group Genomewide association study of severe Covid-19 with respiratory failure. N. Engl. J. Med. 2020;383(16):1522–1534. doi: 10.1056/NEJMoa2020283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Nagant C, Ponthieux F, Smet J, et al. A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. Int. J. Infect. Dis. 2020;101:342–345. doi: 10.1016/j.ijid.2020.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES